People living with Alzheimer's and dementia deserve more time.
More than six million Americans are estimated to have Alzheimer’s today, and everyone who has the disease will die of it or with it. There are no survivors. There are no treatments that stop or slow progression of the disease. But what if a medication could delay the progression of Alzheimer’s and give individuals and families more good days together...or even years?
The U.S. Food and Drug Administration (FDA) is currently reviewing aducanumab, a new treatment for Alzheimer’s. A clinical trial of aducanumab reported a 22% reduction in cognitive and functional decline compared to placebo.
Any delay in disease progression for someone with Alzheimer’s can make a very real difference, as we hear so frequently from people who face it. To deny those who face Alzheimer’s and their loved ones an opportunity to have more precious time together is neither equitable nor humane. It’s time for more time for those facing Alzheimer’s.
What would #MoreTime mean for you and your family?
If a breakthrough Alzheimer’s drug could provide more good days with your loved one, what would it mean to you? Use the hashtags #MoreTime and #ENDALZ on Instagram or Twitter to be included in our gallery.